Related Experiment Video

Updated: Aug 24, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment

Heather S Lett1, James A Blumenthal, Michael A Babyak

  • 1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA. lett0002@mc.duke.edu

Psychosomatic Medicine
|June 9, 2004
PubMed

Insights

Depression significantly increases the risk of developing and worsening coronary artery disease (CAD). While effective depression treatments exist, their impact on improving cardiac outcomes for CAD patients requires further study through clinical trials.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Depression is increasingly recognized as a significant factor influencing cardiovascular health.
  • Understanding the link between mental health and heart disease is crucial for comprehensive patient care.

Purpose of the Study:

  • To review the evidence linking depression to the development and progression of coronary artery disease (CAD).
  • To explore potential biobehavioral mechanisms connecting depression and CAD.
  • To assess the current state of treatment outcome studies for depressed CAD patients.

Main Methods:

  • Systematic literature search using MEDLINE.
  • Review of bibliographies from relevant articles.
  • Thematic clustering of identified articles into risk factors, mechanisms, and treatment outcomes.

Main Results:

  • Depression elevates the risk of CAD onset by 1.5-2.0 times in healthy individuals.
  • In patients with existing CAD, depression increases cardiac morbidity and mortality risk by 1.5-2.5 times.
  • Identified mechanisms include impaired treatment adherence, unhealthy lifestyle, autonomic nervous system (ANS) and hypothalamic pituitary adrenal (HPA) axis dysfunction, platelet activation, and inflammation.

Conclusions:

  • Substantial evidence supports a link between depression and adverse cardiovascular outcomes.
  • Effective depression therapies exist, but their efficacy in improving outcomes for depressed CAD patients is not well-established.
  • Further randomized clinical trials are necessary to determine the benefits of treating depression in CAD patients for improved survival and reduced morbidity.
Abstract

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...